Cancer is still a leading cause of death worldwide. Globally, there were an estimated 20 million new cases of cancer and 10 million deaths.
Researchers from Tokyo Metropolitan University have been studying DNA repair by homologous recombination, where the RecA protein repairs breaks in double-stranded DNA by incorporating a
It is now well documented that the coronavirus outbreak triggered a global health crisis. In this study, researchers wanted to know whether blood-brain barrier impairment
Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have
When Ben Brown, research assistant professor of chemistry, thinks about the opioid epidemic, he views the problem on a molecular level.
A new study that contributes additional data to a growing body of evidence demonstrating disparities in restraint use in the emergency department (ED) has been
The FDA on Friday converted its accelerated approval of Johnson & Johnson’s bladder cancer drug Balversa to a full approval. Balversa, also known as erdafitinib,
Here are the latest data from ASCO’s Gastrointestinal Cancers Symposium: Imfinzi combo extends progression-free survival in liver cancer: In a Phase III trial, AstraZeneca’s Imfinzi
This past week, Sen. Ron Johnson (R-WI) pressed public health officials over concerns that Covid-19 shots from certain lots are associated with a greater risk
AstraZeneca’s add-on pill for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) won its first approval in Japan, the company announced Friday. The drug, an